Literature DB >> 2445406

Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand.

M Spedding1, A K Mir.   

Abstract

1 Palmitoyl carnitine, a lipid metabolite which accumulates in cytoplasmic membranes during ischaemia, has been shown to resemble the Ca2+ channel activator, Bay K 8644, in K+-depolarized smooth muscle. Palmitoyl carnitine caused concentration-dependent (1-1000 mumol l-1) augmentations in the sensitivity to Ca2+ of K+-depolarized taenia preparations from the guinea-pig caecum. The (+/-)-isomer was equieffective with the (-)-isomer, whereas carnitine was ineffective and palmitic acid relaxed the tissues. The shift to the left of Ca2+ concentration-response curves induced by palmitoyl carnitine (100 mumol l-1) was additive with that of Bay K 8644 (1 mumol l-1). 2 The interactions of palmitoyl carnitine with the different classes of calcium-antagonist were similar to those seen with Bay K 8644. Schild plots of the calcium-antagonist effects of nifedipine were shifted to the right following preincubation of the taenia with palmitoyl carnitine (30-300 mumol l-1). The inhibitory effects of verapamil were especially sensitive to palmitoyl carnitine (100 mumol l-1). Whereas the potency of diltiazem as a calcium-antagonist was reduced by palmitoyl carnitine (100 mumol l-1), the inhibitory effects of the lipophilic class III calcium-antagonists, cinnarizine and flunarizine, were entirely resistant to palmitoyl carnitine (100 mumol l-1). 3 Although palmitoyl carnitine has detergent properties in high concentrations and lyses red blood cells, these effects were not Ca2+-dependent, nor were they modified by calcium-antagonists. Other detergents did not have selective interactions with Ca2+ channels. 4 Palmitoyl carnitine inhibited [3H]-nitrendipine, [3H]-verapamil and [3H]-diltiazem binding to rat cortical membranes with IC50 values (mumol l-1) of 120 +/- 1, 95 +/- 17 and 120 +/- 15 mumol l-1 respectively. The inhibition showed little temperature-dependence, in contrast to that of Bay K 8644, except for a small reduction in the IC50 value for [3H]-verapamil binding at 37 degrees C (42 +/- 5 mumol l-1). Palmitoyl carnitine interacted selectively with the Ca2+ channel, in that effects on ligand binding to alpha-adrenoceptors, beta-adrenoceptors and 5-HT1A receptors occurred only at 5-10 fold higher concentrations. 5 It is concluded that palmitoyl carnitine, at concentrations which have previously been shown to occur in the cytoplasm during myocardial ischaemia, may interact directly with Ca2+ channels and may therefore be considered as an endogenous modulator of channel function. The site of action differs from that of other agents.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445406      PMCID: PMC1853649          DOI: 10.1111/j.1476-5381.1987.tb11343.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  In vitro effects of palmitylcarnitine on cardiac plasma membrane Na,K-ATPase, and sarcoplasmic reticulum Ca2+-ATPase and Ca2+ transport.

Authors:  R J Adams; D W Cohen; S Gupte; J D Johnson; E T Wallick; T Wang; A Schwartz
Journal:  J Biol Chem       Date:  1979-12-25       Impact factor: 5.157

2.  Effects of excess free fatty acids on mechanical and metabolic function in normal and ischemic myocardium in swine.

Authors:  A J Liedtke; S Nellis; J R Neely
Journal:  Circ Res       Date:  1978-10       Impact factor: 17.367

3.  Phospholipid-sensitive Ca2+-dependent protein kinase from heart. II. Substrate specificity and inhibition by various agents.

Authors:  B C Wise; D B Glass; C H Chou; R L Raynor; N Katoh; R C Schatzman; R S Turner; R F Kibler; J F Kuo
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

4.  The influence of resting membrane potential on the effect of verapamil on atria.

Authors:  J Linden; G Brooker
Journal:  J Mol Cell Cardiol       Date:  1980-03       Impact factor: 5.000

5.  Substrate proteins for calmodulin-sensitive and phospholipid-sensitive Ca2+-dependent protein kinases in heart, and inhibition of their phosphorylation by palmitoylcarnitine.

Authors:  N Katoh; R W Wrenn; B C Wise; M Shoji; J F Kuo
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

6.  Electrophysiological effects of amphiphiles on canine purkinje fibers. Implications for dysrhythmia secondary to ischemia.

Authors:  P B Corr; D W Snyder; M E Cain; W A Crafford; R W Gross; B E Sobel
Journal:  Circ Res       Date:  1981-08       Impact factor: 17.367

7.  Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium.

Authors:  A M Katz; F C Messineo
Journal:  Circ Res       Date:  1981-01       Impact factor: 17.367

8.  Assessment of "Ca2+ -antagonist" effects of drugs in K+ -depolarized smooth muscle. Differentiation of antagonist subgroups.

Authors:  M Spedding
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

9.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

Review 10.  Metabolic products and myocardial ischemia.

Authors:  J R Neely; D Feuvray
Journal:  Am J Pathol       Date:  1981-02       Impact factor: 4.307

View more
  17 in total

Review 1.  Cardiac metabolism in heart failure: implications beyond ATP production.

Authors:  Torsten Doenst; Tien Dung Nguyen; E Dale Abel
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

Review 2.  Metabolic cardiomyopathies.

Authors:  B Guertl; C Noehammer; G Hoefler
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

3.  Interaction of palmitoyl carnitine with calcium antagonists in myocytes.

Authors:  L Patmore; G P Duncan; M Spedding
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

4.  The effects of novel vasodilator long chain acyl carnitine esters in the isolated perfused heart of the rat.

Authors:  D N Criddle; G H Dewar; W B Wathey; B Woodward
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

5.  Interactions of palmitoyl carnitine with the endothelium in rat aorta.

Authors:  I A Dainty; M Bigaud; J C McGrath; M Spedding
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

Review 6.  Hypertension, calcium channel and pyridoxine (vitamin B6).

Authors:  K Dakshinamurti; K J Lal; P K Ganguly
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

7.  Palmitoyl-DL-carnitine has calcium-dependent effects on cultured neurones from rat dorsal root ganglia.

Authors:  S R Stapleton; K P Currie; R H Scott; B A Bell
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

8.  Effects of palmitoyl carnitine and related metabolites on the avian Ca(2+)-ATPase and Ca2+ release channel.

Authors:  E Dumonteil; H Barré; G Meissner
Journal:  J Physiol       Date:  1994-08-15       Impact factor: 5.182

9.  Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation.

Authors:  P B Corr; M H Creer; K A Yamada; J E Saffitz; B E Sobel
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

10.  Effects of some L-carnitine derivatives on heart membrane ATPases.

Authors:  N S Dhalla; F Kolár; K R Shah; R Ferrari
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.